Arla Foods Ingredients has announced that the UK’s Competition and Markets Authority has approved its acquisition of Volac’s Whey Nutrition business.
Arla Foods Ingredients has announced that the UK’s Competition and Markets Authority has approved its acquisition of Volac’s Whey Nutrition business. The companies originally signed the acquisition agreement on April 18, 2024.
“This is a very welcome decision at a time when demand for high-quality whey ingredients is growing,” said Luis Cubel, group vice president and managing director of Arla Foods Ingredients in a statement. “It means we’re a step closer to a significant acquisition that would consolidate our position as a leader in the whey nutrition space. We will now move forward with the formal process necessary to make Volac’s Whey Nutrition business part of Arla Foods Ingredients. Once that is complete, we will be able to comment further on the many advantages of bringing together these two major manufacturers of whey ingredients – not just for both companies, but also for our customers and the industry as a whole.”
“We were always confident that Arla Foods Ingredients had the necessary expertise and values to take our Whey Nutrition business to the next level, and we are delighted to have reached this important step in the acquisition process,” added James Neville, joint owner of Volac on behalf of the Neville family. “It’s great news for Volac Whey Nutrition, and for the whey ingredients sector, that these two innovative companies have been allowed to join forces.”
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.